1. The landscape of genetic aberrations in myxofibrosarcoma.
- Author
-
Takeuchi, Yasuhide, Yoshida, Kenichi, Halik, Adriane, Kunitz, Annegret, Suzuki, Hiromichi, Kakiuchi, Nobuyuki, Shiozawa, Yusuke, Yokoyama, Akira, Inoue, Yoshikage, Hirano, Tomonori, Yoshizato, Tetsuichi, Aoki, Kosuke, Fujii, Yoichi, Nannya, Yasuhito, Makishima, Hideki, Pfitzner, Berit Maria, Bullinger, Lars, Hirata, Masahiro, Jinnouchi, Keita, and Shiraishi, Yuichi
- Subjects
LOCUS (Genetics) ,SARCOMA ,GENES ,GENETICS - Abstract
Myxofibrosarcoma (MFS) is a rare subtype of sarcoma, whose genetic basis is poorly understood. We analyzed 69 MFS cases using whole‐genome (WGS), whole‐exome (WES) and/or targeted‐sequencing (TS). Newly sequenced genomic data were combined with additional deposited 116 MFS samples. WGS identified a high number of structural variations (SVs) per tumor most frequently affecting the TP53 and RB1 loci, 40% of tumors showed a BRCAness‐associated mutation signature, and evidence of chromothripsis was found in all cases. Most frequently mutated/copy number altered genes affected known disease drivers such as TP53 (56.2%), CDKN2A/B (29.7%), RB1 (27.0%), ATRX (19.5%) and HDLBP (18.9%). Several previously unappreciated genetic aberrations including MUC17, FLG and ZNF780A were identified in more than 20% of patients. Longitudinal analysis of paired diagnosis and relapse time points revealed a 1.2‐fold mutation number increase accompanied with substantial changes in clonal composition over time. Our study highlights the genetic complexity underlying sarcomagenesis of MFS. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF